JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Quidel Corp

Fechado

11.89 -1.08

Visão Geral

Variação de preço das ações

24h

Atual

Mín

11.81

Máximo

12.23

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+71.68% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-483M

726M

Abertura anterior

12.97

Fecho anterior

11.89

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de abr. de 2026, 00:00 UTC

Notícias Principais

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 de abr. de 2026, 23:33 UTC

Ganhos

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 de abr. de 2026, 22:40 UTC

Ganhos

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 de abr. de 2026, 22:10 UTC

Aquisições, Fusões, Aquisições de Empresas

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 de abr. de 2026, 21:11 UTC

Ganhos

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 de abr. de 2026, 21:01 UTC

Ganhos

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 de abr. de 2026, 23:46 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

22 de abr. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 de abr. de 2026, 23:34 UTC

Conversa de Mercado
Notícias Principais

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 de abr. de 2026, 23:16 UTC

Ganhos

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 de abr. de 2026, 23:15 UTC

Ganhos

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 de abr. de 2026, 22:54 UTC

Ganhos

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 de abr. de 2026, 22:54 UTC

Ganhos

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 de abr. de 2026, 22:52 UTC

Ganhos

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 de abr. de 2026, 22:51 UTC

Ganhos

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 de abr. de 2026, 22:31 UTC

Ganhos

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 de abr. de 2026, 22:31 UTC

Ganhos

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 de abr. de 2026, 22:30 UTC

Ganhos

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 de abr. de 2026, 22:30 UTC

Ganhos

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 de abr. de 2026, 22:29 UTC

Ganhos

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 de abr. de 2026, 22:28 UTC

Ganhos

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 de abr. de 2026, 22:28 UTC

Ganhos

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 de abr. de 2026, 22:27 UTC

Ganhos

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 de abr. de 2026, 22:06 UTC

Conversa de Mercado
Ganhos

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 de abr. de 2026, 21:55 UTC

Aquisições, Fusões, Aquisições de Empresas

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 de abr. de 2026, 21:47 UTC

Ganhos

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 de abr. de 2026, 21:37 UTC

Ganhos

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 de abr. de 2026, 21:34 UTC

Ganhos

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 de abr. de 2026, 21:29 UTC

Ganhos

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 de abr. de 2026, 21:20 UTC

Conversa de Mercado
Ganhos

Tesla Expands Manufacturing to Chips -- Market Talk

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

71.68% parte superior

Previsão para 12 meses

Média 20.67 USD  71.68%

Máximo 30 USD

Mínimo 15 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat